{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:30:35Z","timestamp":1794472235125,"version":"4.9.1"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,6,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Selecting the optimal antiplatelet agent in patients who have received percutaneous coronary intervention is especially important in those with diabetes due to the heightened risk of ischemic events in this population. Studies on the efficacy and safety of clopidogrel vs aspirin for long-term maintenance after percutaneous coronary intervention in patients with diabetes are lacking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate cardiovascular outcomes with clopidogrel vs aspirin in patients with and without diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This was a post hoc analysis of the HOST-EXAM randomized clinical trial, an investigator-initiated, prospective, randomized, open-label, multicenter trial performed at 37 centers in Korea. Patients who received dual antiplatelet therapy without clinical events for 6 to 18 months after percutaneous coronary intervention with drug-eluting stents were enrolled from March 2014 to May 2018 with follow-up at 6, 12, 18, and 24 months. All 5438 patients in the original trial were included in this analysis, which was conducted from June to October 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions and Exposures<\/jats:title><jats:p>Enrolled patients were randomized 1:1 to clopidogrel or aspirin monotherapy. Subgroup analyses were performed by the presence of diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcome was primary composite end point of all-cause death, nonfatal myocardial infarction, stroke, readmission due to acute coronary syndrome, and major bleeding (Bleeding Academic Research Consortium type 3 or 5) at 24-month follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 5438 patients (mean [SD] age, 63.5 [10.7] years; 1384 [25.5%] female), 1860 (34.2%) had diabetes (925 in the clopidogrel arm and 935 in the aspirin arm), and 5338 (98.2%) completed follow-up. The rate of the primary composite end point was significantly lower in the clopidogrel group compared to the aspirin group in patients with diabetes (6.3% vs 9.2%; hazard ratio [HR], 0.69; 95% CI, 0.49-0.96; <jats:italic>P<\/jats:italic>\u2009=\u2009.03; absolute risk difference [ARD], 2.7%; number needed to treat [NNT], 37) and without diabetes (5.3% vs 7.0%; HR, 0.76; 95% CI, 0.58-1.00; <jats:italic>P<\/jats:italic>\u2009=\u2009.046; ARD, 1.6%, NNT, 63; <jats:italic>P<\/jats:italic> for interaction\u2009=\u2009.65). The presence of diabetes was not associated with a difference in benefit observed with clopidogrel monotherapy over aspirin for the thrombotic composite end point (HR, 0.68; 95% CI, 0.45-1.04 for patients with diabetes vs HR, 0.68; 95% CI, 0.49-0.93 for those without; <jats:italic>P<\/jats:italic> for interaction\u2009=\u2009.99) and any bleeding with Bleeding Academic Research Consortium 2, 3, or 5 (HR, 0.65; 95% CI, 0.39-1.09 for patients with diabetes vs HR, 0.74; 95% CI, 0.48-1.13 for those without; <jats:italic>P<\/jats:italic> for interaction\u2009=\u2009.71).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion and Relevance<\/jats:title><jats:p>In this study, clopidogrel monotherapy was associated with a lower rate of the primary composite end point compared to aspirin monotherapy as long-term maintenance therapy after dual antiplatelet therapy for coronary stenting in both patients with and without diabetes. Clopidogrel might thus be considered rather than aspirin in patients who have undergone coronary stenting and successfully completed dual antiplatelet therapy, regardless of diabetes status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02044250\">NCT02044250<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2023.0592","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:02:06Z","timestamp":1681297326000},"page":"535","source":"Crossref","is-referenced-by-count":15,"title":["Aspirin vs Clopidogrel for Long-term Maintenance After Coronary Stenting in Patients With Diabetes"],"prefix":"10.1001","volume":"8","author":[{"given":"Tae-Min","family":"Rhee","sequence":"first","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[{"name":"Chungbuk National University College of Medicine, Cheongju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[{"name":"Korea University Guro Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heesun","family":"Lee","sequence":"additional","affiliation":[{"name":"Seoul National University Healthcare System Gangnam Center, Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Mo","family":"Yang","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Heon","family":"Kwak","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[{"name":"Seoul National University Bundang Hospital, Seongnam, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Yong","family":"Shin","sequence":"additional","affiliation":[{"name":"Soonchunhyang University Cheonan Hospital, Cheonan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Kyeong","family":"Kim","sequence":"additional","affiliation":[{"name":"Busan Paik Hospital, Inje University, Busan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyeon","family":"Oh","sequence":"additional","affiliation":[{"name":"Samsung Changwon Hospital, Sungkyunkwan University, Changwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Chonnam National University Hospital, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Kangwon National University, School of Medicine, Chuncheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Kangnam Sacred Heart Hospital, Hallym University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ho","family":"Hur","sequence":"additional","affiliation":[{"name":"Keimyung University Dongsan Hospital, Daegu, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junghan","family":"Yoon","sequence":"additional","affiliation":[{"name":"Yonsei University Wonju Severance Christian Hospital, Wonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Kyu","family":"Han","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[{"name":"Ulsan University Hospital, Ulsan, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital and Seoul National University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HOST-EXAM Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Bum","family":"Won","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Ho","family":"Park","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bum Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Wook","family":"Lim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Haeng","family":"Cho","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Woon","family":"Jeon","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoo-Rok","family":"Han","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon-Woong","family":"Moon","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Kyu","family":"Oh","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ung","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo-Yong","family":"Rhee","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo-Il","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Yi","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yun","family":"Lee","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Uk","family":"Lee","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Yeon","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Kyung","family":"Jeon","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Soo","family":"Cha","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Ho","family":"Jo","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kean","family":"Ryu","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Woo","family":"Suh","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Hee","family":"Choi","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung-Il","family":"Woo","sequence":"additional","affiliation":[{"name":"for the HOST-EXAM Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"hoi230014r1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization.","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"10293","key":"hoi230014r2","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/S0140-6736(21)01063-1","article-title":"Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial.","volume":"397","author":"Koo","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"hoi230014r3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"hoi230014r4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease.","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"hoi230014r5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ahj.2016.12.001","article-title":"A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.","volume":"185","author":"Lee","year":"2017","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"hoi230014r6","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"36","author":"Association","year":"2013","journal-title":"Diabetes Care"},{"issue":"10235","key":"hoi230014r7","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/S0140-6736(20)30315-9","article-title":"Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis.","volume":"395","author":"Chiarito","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"hoi230014r8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S0002-9149(02)02567-5","article-title":"Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.","volume":"90","author":"Bhatt","year":"2002","journal-title":"Am J Cardiol"},{"issue":"1","key":"hoi230014r9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002816","article-title":"Clopidogrel Versus aspirin as an antiplatelet monotherapy after 12-month dual-antiplatelet therapy in the era of drug-eluting stents.","volume":"9","author":"Park","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"hoi230014r10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/CIRCULATIONAHA.122.062770","article-title":"Aspirin vs. clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study.","volume":"147","author":"Kang","year":"2023","journal-title":"Circulation"},{"issue":"10","key":"hoi230014r11","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery.","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"hoi230014r12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00125-007-0898-3","article-title":"Aspirin resistance and diabetes mellitus.","volume":"51","author":"Ajjan","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"hoi230014r13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2005.10.042","article-title":"Coagulation and atherothrombotic disease.","volume":"186","author":"Ajjan","year":"2006","journal-title":"Atherosclerosis"},{"issue":"8","key":"hoi230014r14","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"issue":"20","key":"hoi230014r15","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.jacc.2013.07.051","article-title":"Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evaluation).","volume":"62","author":"Acharjee","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"hoi230014r16","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a Report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines.","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"17","key":"hoi230014r17","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.jacc.2017.09.001","article-title":"How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD.","volume":"70","author":"Hong","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi230014r18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jacc.2006.03.038","article-title":"Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.","volume":"48","author":"Angiolillo","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2803932\/jamacardiology_rhee_2023_oi_230014_1686672877.90237.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:01:52Z","timestamp":1686740512000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2803932"}},"subtitle":["A Post Hoc Analysis of the HOST-EXAM Trial"],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.0592","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}